<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34946430</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9032</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>Healthcare (Basel, Switzerland)</Title><ISOAbbreviation>Healthcare (Basel)</ISOAbbreviation></Journal><ArticleTitle>Trends in COVID-19 Health Disparities in North Carolina: Preparing the Field for Long-Haul Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1704</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/healthcare9121704</ELocationID><Abstract><AbstractText>Long-term coronavirus disease 2019 (long-COVID) refers to persistent symptoms of SARS-CoV-2 (COVID-19) lingering beyond four weeks of initial infection. Approximately 30% of COVID-19 survivors develop prolonged symptoms. Communities of color are disproportionately affected by comorbidities, increasing the risk of severe COVID-19 and potentially leading to long-COVID. This study aims to identify trends in health disparities related to COVID-19 cases, which can help unveil potential populations at risk for long-COVID. All North Carolina (NC) counties (<i>n</i> = 100) were selected as a case study. Cases and vaccinations per 1000 population were calculated based on the NC Department of Health and Human Services COVID-19 dashboard with reports current as of 8 October 2021, which were stratified by age groups and race/ethnicity. Then, NC COVID-19 cases were correlated to median household income, poverty, population density, and social vulnerability index themes. We observed a negative correlation between cases (<i>p</i> &lt; 0.05) and deaths (<i>p</i> &lt; 0.01) with both income and vaccination status. Moreover, there was a significant positive association between vaccination status and median household income (<i>p</i> &lt; 0.01). Our results highlight the prevailing trend between exacerbated COVID-19 infection and low-income/under-resourced communities. Consequently, efforts and resources should be channeled to these communities to effectively monitor, diagnose, and treat against COVID-19 and potentially prevent an overwhelming number of long-COVID cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Muratori Holanda</LastName><ForeName>Thais</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alberico</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rios-Colon</LastName><ForeName>Leslimar</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4849-3399</Identifier><AffiliationInfo><Affiliation>Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arthur</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Deepak</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0418-5116</Identifier><AffiliationInfo><Affiliation>Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 MD015970</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54MD012392</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01MD012767</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Healthcare (Basel)</MedlineTA><NlmUniqueID>101666525</NlmUniqueID><ISSNLinking>2227-9032</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">health disparity</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">persistent</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34946430</ArticleId><ArticleId IdType="pmc">PMC8702005</ArticleId><ArticleId IdType="doi">10.3390/healthcare9121704</ArticleId><ArticleId IdType="pii">healthcare9121704</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  WHO Coronavirus (COVID-19) Dashboard With Vaccination Data.  [(accessed on 31 August 2021)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J., McDonald D., Magedson A., Wolf C.R., Chu H.Y. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S.D., Talwar A., Lee J.T. A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications. JAMA. 2020;324:2251&#x2013;2252. doi: 10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence . Overview|COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. NICE; London, UK: 2020. pp. 1&#x2013;35. NICE Guideline.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The Lasting Misery of Coronavirus Long-Haulers. Nature. 2020;585:339&#x2013;341. doi: 10.1038/d41586-020-02598-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02598-6</ArticleId><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Florencio L.L. Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int. J. Environ. Res. Public Health. 2021;18:2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P., Arora U., Kumar A., Wig N. The &#x201c;Post-COVID&#x201d; Syndrome: How Deep Is the Damage? J. Med. Virol. 2021;93:673&#x2013;674. doi: 10.1002/jmv.26465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26465</ArticleId><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  COVID-19 Racial and Ethnic Disparities.  [(accessed on 31 August 2021)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/racial-ethnic-disparities/index.html.</Citation></Reference><Reference><Citation>Webb Hooper M., N&#xe1;poles A.M., P&#xe9;rez-Stable E.J. COVID-19 and Racial/Ethnic Disparities. JAMA J. Am. Med. Assoc. 2020;323:2466&#x2013;2467. doi: 10.1001/jama.2020.8598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8598</ArticleId><ArticleId IdType="pmc">PMC9310097</ArticleId><ArticleId IdType="pubmed">32391864</ArticleId></ArticleIdList></Reference><Reference><Citation>NCDHHS  Cases|NC COVID-19.  [(accessed on 31 August 2021)]; Available online:  https://covid19.ncdhhs.gov/dashboard/cases.</Citation></Reference><Reference><Citation>NCDHHS  COVID-19 North Carolina Dashboard.  [(accessed on 31 August 2021)]; Available online:  https://covid19.ncdhhs.gov/dashboard.</Citation></Reference><Reference><Citation>U.S. Census Bureau  2019&#x2013;2023 ACS 5-Year Data Profile.  [(accessed on 31 August 2021)]; Available online:  https://www.census.gov/acs/www/data/data-tables-and-tools/data-profiles/2019/</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Agency for Toxic Substances and Disease Registry. Geospatial Research, Analysis, and Services Program  CDC/ATSDR Social Vulnerability Index 2018 Database North Carolina.  [(accessed on 31 August 2021)]; Available online:  https://www.atsdr.cdc.gov/placeandhealth/svi/data_documentation_download.html.</Citation></Reference><Reference><Citation>Raifman M.A., Raifman J.R. Disparities in the Population at Risk of Severe Illness from COVID-19 by Race/Ethnicity and Income. Am. J. Prev. Med. 2020;59:137&#x2013;139. doi: 10.1016/j.amepre.2020.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7183932</ArticleId><ArticleId IdType="pubmed">32430225</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamkiewicz G., Zota A.R., Patricia Fabian M., Chahine T., Julien R., Spengler J.D., Levy J.I. Moving Environmental Justice Indoors: Understanding Structural Influences on Residential Exposure Patterns in Low-Income Communities. Am. J. Public Health. 2011;101((Suppl. 1)):238&#x2013;245. doi: 10.2105/AJPH.2011.300119.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2011.300119</ArticleId><ArticleId IdType="pmc">PMC3222513</ArticleId><ArticleId IdType="pubmed">21836112</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger Z., Altiery De Jesus V., Assoumou S.A., Greenhalgh T. Long COVID and Health Inequities: The Role of Primary Care. Milbank Q. 2021;99:519&#x2013;541. doi: 10.1111/1468-0009.12505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1468-0009.12505</ArticleId><ArticleId IdType="pmc">PMC8241274</ArticleId><ArticleId IdType="pubmed">33783907</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID-Mechanisms, Risk Factors, and Management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown L., Billings V., Pilkington W., Kumar D. Facilitating COVID-19 Testing in Historically Marginalized Populations by Leveraging Community Partnerships. N. C. Med. J. 2021;82:301. doi: 10.18043/ncm.82.4.301.</Citation><ArticleIdList><ArticleId IdType="doi">10.18043/ncm.82.4.301</ArticleId><ArticleId IdType="pubmed">34230190</ArticleId></ArticleIdList></Reference><Reference><Citation>Izda V., Jeffries M.A., Sawalha A.H. COVID-19: A Review of Therapeutic Strategies and Vaccine Candidates. Clin Immunol. 2021;222:108634. doi: 10.1016/j.clim.2020.108634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108634</ArticleId><ArticleId IdType="pmc">PMC7670907</ArticleId><ArticleId IdType="pubmed">33217545</ArticleId></ArticleIdList></Reference><Reference><Citation>NCDHHS  Vaccinations|NC COVID-19.  [(accessed on 31 August 2021)]; Available online:  https://covid19.ncdhhs.gov/dashboard/vaccinations.</Citation></Reference><Reference><Citation>Fowlkes A., Gaglani M., Groover K., Thiese M.S., Tyner H., Ellingson K., HEROES-RECOVER Cohorts Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance&#x2014;Eight U.S. Locations, December 2020-August 2021. MMWR. Morb. Mortal. Wkly. Rep. 2021;70:1167&#x2013;1169. doi: 10.15585/mmwr.mm7034e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7034e4</ArticleId><ArticleId IdType="pmc">PMC8389394</ArticleId><ArticleId IdType="pubmed">34437521</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk Factors and Disease Profile of Post-Vaccination SARS-CoV-2 Infection in UK Users of the COVID Symptom Study App: A Prospective, Community-Based, Nested, Case-Control Study. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(21)00460-6. in press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergwerk M., Gonen T., Lustig Y., Amit S., Lipsitch M., Cohen C., Mandelboim M., Gal Levin E., Rubin C., Indenbaum V., et al. COVID-19 Breakthrough Infections in Vaccinated Health Care Workers. N. Engl. J. Med. 2021;385:1474&#x2013;1484. doi: 10.1056/NEJMoa2109072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109072</ArticleId><ArticleId IdType="pmc">PMC8362591</ArticleId><ArticleId IdType="pubmed">34320281</ArticleId></ArticleIdList></Reference><Reference><Citation>Machingaidze S., Wiysonge C.S. Understanding COVID-19 Vaccine Hesitancy. Nat. Med. 2021;27:1338&#x2013;1339. doi: 10.1038/s41591-021-01459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01459-7</ArticleId><ArticleId IdType="pubmed">34272500</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson S.H., Mansatta K., Mallett G., Harris V., Emary K.R.W., Pollard A.J. What Defines an Efficacious COVID-19 Vaccine? A Review of the Challenges Assessing the Clinical Efficacy of Vaccines against SARS-CoV-2. Lancet Infect. Dis. 2021;21:e26&#x2013;e35. doi: 10.1016/S1473-3099(20)30773-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30773-8</ArticleId><ArticleId IdType="pmc">PMC7837315</ArticleId><ArticleId IdType="pubmed">33125914</ArticleId></ArticleIdList></Reference><Reference><Citation>Betsch C., Schmid P., Heinemeier D., Korn L., Holtmann C., B&#xf6;hm R. Beyond Confidence: Development of a Measure Assessing the 5C Psychological Antecedents of Vaccination. PLoS ONE. 2018;13:e0208601. doi: 10.1371/journal.pone.0208601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208601</ArticleId><ArticleId IdType="pmc">PMC6285469</ArticleId><ArticleId IdType="pubmed">30532274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hildreth J.E.K., Alcendor D.J. Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity. Vaccines. 2021;9:489. doi: 10.3390/vaccines9050489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9050489</ArticleId><ArticleId IdType="pmc">PMC8151325</ArticleId><ArticleId IdType="pubmed">34064726</ArticleId></ArticleIdList></Reference><Reference><Citation>Strully K.W., Harrison T.M., Pardo T.A., Carleo-Evangelist J. Strategies to Address COVID-19 Vaccine Hesitancy and Mitigate Health Disparities in Minority Populations. Front. Public Health. 2021;9 doi: 10.3389/fpubh.2021.645268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.645268</ArticleId><ArticleId IdType="pmc">PMC8102721</ArticleId><ArticleId IdType="pubmed">33968884</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L.H., Joshi A.D., Drew D.A., Merino J., Ma W., Lo C.-H., Kwon S., Wang K., Graham M.S., Polidori L., et al. Racial and Ethnic Differences in COVID-19 Vaccine Hesitancy and Uptake. medRxiv Prepr. Serv. Health Sci. 2021:1&#x2013;49. doi: 10.1101/2021.02.25.21252402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.25.21252402</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty I.A., Pilkington W., Brown L., Billings V., Hoffler U., Paulin L., Kimbro K.S., Baker B., Zhang T., Locklear T., et al. COVID-19 Vaccine Hesitancy in Underserved Communities of North Carolina. medRxiv Prepr. Serv. Health Sci. 2021:1&#x2013;30. doi: 10.1371/journal.pone.0248542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248542</ArticleId><ArticleId IdType="pmc">PMC8559933</ArticleId><ArticleId IdType="pubmed">34723973</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvani A.P., Parpia A.S., Pandey A., Zimmer C., Kahn J.G., Fitzpatrick M.C. The Imperative for Universal Healthcare to Curtail the COVID-19 Outbreak in the USA. EClinicalMedicine. 2020;23:1&#x2013;2. doi: 10.1016/j.eclinm.2020.100380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100380</ArticleId><ArticleId IdType="pmc">PMC7231536</ArticleId><ArticleId IdType="pubmed">32426707</ArticleId></ArticleIdList></Reference><Reference><Citation>The Catastrophic Cost of Uninsurance: COVID-19 Cases and Deaths Closely Tied to America&#x2019;s Health Coverage Gaps&#x2014;Families Usa.  [(accessed on 17 November 2021)].  Available online:  https://familiesusa.org/resources/the-catastrophic-cost-of-uninsurance-covid-19-cases-and-deaths-closely-tied-to-americas-health-coverage-gaps/</Citation></Reference><Reference><Citation>United States Census Bureau . Health Insurance Coverage in the United States. United States Census Bureau; Washington, DC, USA: 2020.</Citation></Reference><Reference><Citation>Gerry J.M., Weiser T.G., Spain D.A., Staudenmayer K.L. Uninsured Status May Be More Predictive of Outcomes among the Severely Injured than Minority Race. Injury. 2016;47:197&#x2013;202. doi: 10.1016/j.injury.2015.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2015.09.003</ArticleId><ArticleId IdType="pmc">PMC4698055</ArticleId><ArticleId IdType="pubmed">26396045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>